| Date Filed | Type | Description |
| 08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
4
| SOOD NITIN (Chief Commercial Officer, MRD) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 5,652 shares
@ $6.78, valued at
$38.3k
Sold 10,550 shares
@ $6.54, valued at
$69k
|
|
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/02/2023 |
8-K
| Quarterly results |
| 07/03/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 06/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/06/2023 |
4
| PETERSON TYCHO (CFO) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 38,000 shares
@ $7.16, valued at
$272.1k
|
|
| 06/01/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/09/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 05/03/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/03/2023 |
8-K
| Quarterly results |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2023 |
4
| Pellini Michael J (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 03/08/2023 |
4
| OWEN KATEY EINTERZ (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 03/08/2023 |
4
| NEUPERT PETER M (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 03/08/2023 |
4
| HERSHBERG ROBERT (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 03/08/2023 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 03/08/2023 |
4
| Conroy Kevin T (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 03/08/2023 |
4
| Trigg Leslie (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 03/08/2023 |
4
| PISKEL KYLE (Principal Accounting Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 43,735 shares
@ $0
Sold 3,300 shares
@ $8.57, valued at
$28.3k
Sold 229 shares
@ $8.58, valued at
$2k
|
|
| 03/08/2023 |
4
| LO FRANCIS (Chief People Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 85,697 shares
@ $0
Sold 6,816 shares
@ $8.57, valued at
$58.4k
Granted 128,599 options to buy
@ $8.46, valued at
$1.1M
|
|
| 03/08/2023 |
4
| Taylor Stacy L (SVP and General Counsel) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 85,697 shares
@ $0
Sold 5,491 shares
@ $8.57, valued at
$47.1k
Sold 13,387 shares
@ $8.6, valued at
$115.1k
Granted 128,599 options to buy
@ $8.46, valued at
$1.1M
|
|
| 03/08/2023 |
4
| ADAMS R MARK (COO) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 88,652 shares
@ $0
Sold 6,529 shares
@ $8.57, valued at
$56k
Sold 17,155 shares
@ $8.6, valued at
$147.5k
Granted 133,033 options to buy
@ $8.46, valued at
$1.1M
|
|
| 03/08/2023 |
4
| PETERSON TYCHO (CFO) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 118,203 shares
@ $0
Granted 177,377 options to buy
@ $8.46, valued at
$1.5M
|
|
| 03/08/2023 |
4
| BENZENO SHARON (Chief Commercial Ofc Imm Med) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 132,979 shares
@ $0
Sold 11,749 shares
@ $8.57, valued at
$100.7k
Granted 199,549 options to buy
@ $8.46, valued at
$1.7M
|
|
| 03/08/2023 |
4
| SOOD NITIN (Chief Commercial Officer, MRD) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 132,979 shares
@ $0
Sold 6,661 shares
@ $8.57, valued at
$57.1k
Sold 9,813 shares
@ $8.6, valued at
$84.4k
Granted 199,549 options to buy
@ $8.46, valued at
$1.7M
|
|
| 03/08/2023 |
4
| RUBINSTEIN JULIE (President) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 132,979 shares
@ $0
Sold 22,668 shares
@ $8.57, valued at
$194.3k
Granted 199,549 options to buy
@ $8.46, valued at
$1.7M
|
|
| 03/08/2023 |
4
| ROBINS HARLAN S (Chief Scientific Officer) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 354,610 shares
@ $0 |
|
| 03/08/2023 |
4
| ROBINS CHAD M (CEO and Chairman) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 354,610 shares
@ $0 |
|
| 02/14/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/10/2023 |
SC 13G
| ARK Investment Management LLC reports a 6.4% stake in Adaptive Biotechnologies Corporation |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 8.2% stake in Adaptive Biotechnologies Corp. |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|